ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Recommended management strategies for women with epilepsy during pre-pregnancy, pregnancy, delivery, and early postpartum

Recommended management strategies for women with epilepsy during pre-pregnancy, pregnancy, delivery, and early postpartum
Timeline Preconception Pregnancy first trimester Pregnancy second trimester Pregnancy third trimester Postpartum (approximately 6 weeks)
Clinic visits with the neurologist, with discussion topics
  1. Review the history, imaging and EEG findings to confirm diagnosis and ascertain the epilepsy syndrome
  2. Balance seizure risks against AED risks, by type of AED and dose of AED (eg, major congenital malformation, adverse neonatal outcomes, adverse neurodevelopment).
  3. Valproate should be avoided whenever possible. If on valproate, consider whether all other appropriate options have been tried.
  4. Consider whether the patient could be on monotherapy with lower dosage. Consider AED withdrawal if appropriate (epilepsy in remission and high likelihood of successful withdrawal).
  5. Seizure control before pregnancy is important if possible. Counsel the patient about risks of increased seizure rates or severity during a pregnancy, especially if AEDs are stopped abruptly (eg, blunt trauma with risk of foetal loss, injury, or abruptio placentae, decreased foetal oxygenation, increased foetal distress, maternal SUDEP).
  6. Given the incidence of unplanned pregnancies, women with childbearing potential taking AEDs should also be on supplementary folic acid prior to pregnancy and continue throughout pregnancy.
  1. Reinforce AED clearance changes and begin AED level monitoring immediately*, if on an AED with substantial clearance changes.
  2. AED dose adjustments for increased seizures or side effects and to maintain baseline, non-pregnant AED level(s)*.
  3. Re-dose AEDs if emesis occurs shortly after AED intake.
  4. Screening for depression and anxiety.
  1. Continue to monitor changes in AED levels at least monthly*.
  2. AED dose adjustments to maintain baseline level(s)*, and for seizures or side effects.
  3. Review results from prenatal screening tests.
  4. History and neurological examination for signs of increased medication side effects.
  5. Screening for depression and anxiety.
  1. Possible increased risk of seizure worsening peripartum.
  2. Birth plan recommendations from neurology perspective.
  3. Desire to breastfeed with data to support that benefits outweigh theoretical risks.
  4. Strategies to breastfeed but allow some sleep for the mother.
  5. Postpartum AED taper plan (usually determined after an AED level at 34 to 37 weeks gestational age).
  6. Newborn safety and signs for adequate hydration and nutrition if breastfeeding.
  7. History and neurological examination for signs of increased medication side effects.
  8. Screening for depression and anxiety.
  1. Review history of postpartum seizures and/or medication side effects.
  2. Assess for postpartum depression and anxiety.
  3. Assess sleep hygiene and strategies to increase if needed.
  4. History of infant feeding, growth and development.
  5. Neurological examination for signs of medication side effects.
Blood workup for AED levels, if on an AED with clearance changes during pregnancy* Determine optimal individualized baseline pre-pregnancy AED level*. Monthly AED blood levels*. Monthly AED blood levels*. Monthly AED blood levels*. AED blood level if clinically indicated*.
Communication with the patient about AED dosing   Adjustment of AED dosing for seizures or side effects and to maintain baseline, non-pregnant AED levels. Adjustment of AED dosing for seizures or side effects and to maintain baseline, non-pregnant AED levels. Adjustment of AED dosing for seizures or side effects and to maintain baseline, non-pregnant AED levels. Review if postpartum AED taper was followed and adjust further as needed clinically.
Communication between the neurologist and obstetrician
  1. Decision on contraception choice/initiation/discontinuation.
  2. Further adjustment of AED regimen regarding type of AED and dose of AED with lowest foetal risk without compromising seizure control.
  1. Obtain AED levels* (blood can be drawn at more frequent obstetric appointments).
  1. Obtain AED levels*.
  2. Results from screening tests (blood and ultrasound) reviewed and communicated to patient.
  1. Obtain AED levels*.
  2. Coordinate labour and delivery hospital care plan with the obstetrician, neurologist, and patient. Include neonatologist for clinical concerns based on prenatal testing.
Neurologist and obstetrician together:
  1. Develop short-term and long-term plan for contraception.
  2. Discuss future pregnancy plans and preferred timing.
AED: antiepileptic drug.
* In clinical practice settings with resources to obtain AED blood levels.
From: Tomson T, Battino D, Bromley R, et al. Management of epilepsy in pregnancy: a report from the International League Against Epilepsy Task Force on Women and Pregnancy. Epileptic Disord 2019; 21:497. Available at: https://onlinelibrary.wiley.com/doi/10.1684/epd.2019.1105. Copyright © 2019 The Authors. Reproduced under the terms of the Creative Commons Attribution ShareAlike License 4.0.
Graphic 126399 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟